Dr. David A. Brogno, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 461
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: University of Michigan Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NY license 160631 -
Cardiovascular Disease Physician
NY license 160631
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
- Helen Hayes Hospital West Haverstraw, NY
Medical groups
- Trustees of Columbia University in The City of New York (2,296 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 461
- Services billed
- 1,962
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 693 | 380 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 599 | 388 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 155 | 145 |
| Insertion of needle into vein for collection of blood sample | 103 | 85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | 94 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 73 | 69 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 52 | 48 |
| New patient office or other outpatient visit, 45-59 minutes | 45 | 45 |
| Established patient office or other outpatient visit, 20-29 minutes | 45 | 44 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 40 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Suffern, NY | 320 |
| Rosuvastatin Calcium Other prescribers in Suffern, NY | 227 |
| Metoprolol Succinate Other prescribers in Suffern, NY | 200 |
| Eliquis (apixaban) Other prescribers in Suffern, NY | 182 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Suffern, NY | 151 |
| Amlodipine Besylate Other prescribers in Suffern, NY | 148 |
| Losartan Potassium Other prescribers in Suffern, NY | 124 |
| Carvedilol Other prescribers in Suffern, NY | 75 |
| Furosemide Other prescribers in Suffern, NY | 69 |
| Repatha Sureclick (evolocumab) Other prescribers in Suffern, NY | 68 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 14 payments worth $794 in total to this clinician.
| Boston Scientific Corporation | $185 |
|---|---|
| Heartflow, Inc. | $144 |
| Abiomed | $142 |
| Terumo Medical Corporation | $111 |
| Cordis US Corp. | $111 |
| Asahi Intecc USA, Inc. | $100 |
| Food and Beverage | $794 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $21,702 in research payments for these studies, mostly to the institutions running them.
- AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Boston Scientific Corporation · Recruiting · NCT06959524
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.